We are live on ! Find out more
PP

PFS Partners Portfolio holdings

AUM $247M
1-Year Est. Return 29.02%
This Fund
S&P 500
This Quarter Est. Return
-2.13%
1 Year Est. Return
+29.02%
3 Year Est. Return
+63.21%
5 Year Est. Return
10 Year Est. Return
AUM
$113M
AUM Growth
-$6.02M
Cap. Flow
-$3.2M
Cap. Flow %
-2.82%
Top 10 Hldgs %
67.75%
Holding
490
New
11
Increased
110
Reduced
51
Closed
26
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLB icon
426
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
$1.11K ﹤0.01%
28
X
427
DELISTED
US Steel
X
$1.06K ﹤0.01%
33
-1,469
-98% -$41.2K
BLUE
428
DELISTED
bluebird bio
BLUE
$1.03K ﹤0.01%
17
BABA icon
429
Alibaba
BABA
$269B
$955 ﹤0.01%
11
NVO
430
Novo Nordisk
NVO
$216B
$915 ﹤0.01%
10
BHF icon
431
Brighthouse Financial
BHF
$3.63B
$784 ﹤0.01%
16
PLUG icon
432
Plug Power
PLUG
$2.92B
$760 ﹤0.01%
100
ASIX icon
433
AdvanSix
ASIX
$567M
$704 ﹤0.01%
23
FENY icon
434
Fidelity MSCI Energy Index ETF
FENY
$2.02B
$698 ﹤0.01%
28
-142
-84% -$3.41K
AIG icon
435
American International
AIG
$41.9B
$667 ﹤0.01%
11
ATYR
436
aTyr Pharma
ATYR
$46.4M
$632 ﹤0.01%
400
FBIN icon
437
Fortune Brands Innovations
FBIN
$6.12B
$622 ﹤0.01%
10
BCEL
438
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$520 ﹤0.01%
1,990
SCHB icon
439
Schwab US Broad Market ETF
SCHB
$42.8B
$519 ﹤0.01%
30
CHPT icon
440
ChargePoint
CHPT
$133M
$497 ﹤0.01%
5
TSVT
441
DELISTED
2seventy bio
TSVT
$443 ﹤0.01%
113
ADNT icon
442
Adient
ADNT
$1.6B
$415 ﹤0.01%
11
NKTR icon
443
Nektar Therapeutics
NKTR
$2.39B
$356 ﹤0.01%
40
SRL icon
444
Scully Royalty
SRL
$76.7M
$329 ﹤0.01%
58
SPRO icon
445
Spero Therapeutics
SPRO
$68.9M
$303 ﹤0.01%
250
NOK icon
446
Nokia
NOK
$50.8B
$285 ﹤0.01%
76
PSX icon
447
Phillips 66
PSX
$82.9B
$262 ﹤0.01%
2
GM icon
448
General Motors
GM
$74.7B
$231 ﹤0.01%
7
LLYVK icon
449
Liberty Live Group Series C
LLYVK
$9.11B
$193 ﹤0.01%
+6
New +$199
BMTX
450
DELISTED
BM Technologies, Inc.
BMTX
$180 ﹤0.01%
90

Similar funds

PFS Partners's Q3 2023 Portfolio in Review

As of Q3 2023, PFS Partners held 490 positions worth $113M, down 5% from $119M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

PFS Partners's Q3 2023 filing shows 11 new, 110 increased, 51 reduced and 26 closed positions. Its largest new stake was FT Vest US Equity Enhance & Moderate Buffer ETF August: 8,506 shares worth $252K. The largest sale was Invesco QQQ Trust, an estimated $4.29M.

By sector, the portfolio is most concentrated in Financials at 4.2% of assets, up from 3.7% a quarter earlier, followed by Technology and Healthcare.

  • PFS Partners's largest Q3 2023 buy was FT Vest US Equity Enhance & Moderate Buffer ETF August: 8,506 shares worth $252K.
  • PFS Partners added most to Innovator US Small Cap Power Buffer ETF July in Q3 2023, an estimated $4.91M increase.
  • PFS Partners's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $4.29M.
  • PFS Partners fully exited Innovator US Small Cap Power Buffer ETF January in Q3 2023, selling an estimated $4.19M.
  • PFS Partners's ten largest holdings make up 68% of its $113M portfolio in Q3 2023.
  • PFS Partners opened 11 new positions and closed 26 in Q3 2023.
  • PFS Partners's portfolio value fell 5% quarter-over-quarter to $113M.

Based on PFS Partners's 13F filing for Q3 2023, filed 1 Dec 2023.